COVID-19 is primarily a respiratory disease but up to two thirds of hospitalised patients show
evidence of central nervous system (CNS) damage, predominantly ischaemic, in some …

Abstract Introduction Coronavirus disease-19 (COVID-19) pandemic continues to grow all
over the world. Several studies have been performed, focusing on understanding the acute …

Objective We sought to review the literature on cerebrospinal fluid (CSF) testing in patients
with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2. Methods We performed …

Background SARS-CoV-2 can affect the human brain and other neurological structures. An
increasing number of publications report neurological manifestations in patients with COVID …

INTRODUCTION: This paper improves the methodology of the first edition of the rapid living
systematic review started in April 2020, with the aim to gather and present the current …

At the beginning of December 2019, Wuhan, the capital of Hubei Province and a large city of
approximately 11 million persons located in the central region of the People's Republic of …

Despite the international scientific community's commitment to improve clinical knowledge
about coronavirus disease 2019 (COVID‐19), knowledge regarding molecular details …

Increasing data indicate that people infected with COVID-19 are at high risk for developing
long-term neurological complications, such as “brain fog” or cognitive impairment. However …

To listen to the podcast associated with this article, please select one of the following:
iTunes, Google Play, or direct download. Among 2820 inpatients with coronavirus disease …

Background Coronavirus disease 2019 (COVID-19) has been associated with
neuropsychiatric complications ranging from new-onset psychosis to delirium, dysexecutive …